USANA Health Sciences, Inc. (USNA)
NYSE: USNA · Real-Time Price · USD
18.03
-0.10 (-0.55%)
Jun 5, 2026, 4:00 PM EDT - Market closed
USANA Health Sciences Balance Sheet
Financials in millions USD. Fiscal year is February - January.
Millions USD. Fiscal year is Feb - Jan.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 4, 2026 | Jan '26 Jan 3, 2026 | Dec '24 Dec 28, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 162.75 | 158.38 | 181.77 | 330.42 | 288.42 | 239.83 |
Cash & Short-Term Investments | 162.75 | 158.38 | 181.77 | 330.42 | 288.42 | 239.83 |
Cash Growth | -9.39% | -12.87% | -44.99% | 14.56% | 20.26% | -23.11% |
Accounts Receivable | 35.12 | 27.42 | 27.68 | 25.87 | 28.87 | 26.97 |
Inventory | 96.36 | 102.61 | 69.74 | 61.45 | 67.09 | 98.32 |
Total Current Assets | 294.23 | 288.41 | 279.19 | 417.75 | 384.38 | 365.12 |
Net Property, Plant & Equipment | 94.63 | 94.38 | 94.57 | 99.81 | 97.77 | 101.78 |
Other Intangible Assets | 128.9 | 133.15 | 151.82 | 29.92 | 32.43 | 30.44 |
Goodwill | 138.13 | 137.96 | 144.17 | 17.1 | 17.37 | 17.67 |
Other Long-Term Assets | 83.08 | 89.01 | 78.45 | 68.18 | 64.59 | 62.73 |
Total Assets | 738.97 | 742.92 | 748.19 | 632.76 | 596.55 | 577.74 |
Accounts Payable | 16.23 | 17.26 | 11.98 | 10.07 | 11.05 | 13.51 |
Short-Term Debt | 14 | 14 | 23 | 0.79 | - | - |
Other Current Liabilities | 87.01 | 97.3 | 104.64 | 107.99 | 132.78 | 147.28 |
Total Current Liabilities | 117.24 | 128.57 | 139.63 | 118.85 | 143.83 | 160.79 |
Other Long-Term Liabilities | 26.94 | 28.08 | 22.24 | 16.71 | 18.24 | 21.83 |
Total Long-Term Liabilities | 26.94 | 28.08 | 22.24 | 16.71 | 18.24 | 21.83 |
Total Liabilities | 144.18 | 156.64 | 161.86 | 135.56 | 162.08 | 182.62 |
Common Stock | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
Additional Paid-in Capital | 84.73 | 83.54 | 75.82 | 65.66 | 55.6 | 50.01 |
Accumulated Other Comprehensive Income | -14.44 | -16.18 | -22.67 | -13.7 | -12.79 | 0.46 |
Retained Earnings | 473.24 | 465.72 | 478.94 | 445.22 | 391.64 | 344.64 |
Total Common Shareholders' Equity | 543.55 | 533.1 | 532.11 | 497.2 | 434.47 | 395.12 |
Minority Interest | 51.24 | 53.17 | 54.22 | - | - | - |
Shareholders' Equity | 594.79 | 586.27 | 586.33 | 497.2 | 434.47 | 395.12 |
Total Liabilities & Equity | 738.97 | 742.92 | 748.19 | 632.76 | 596.55 | 577.74 |
Total Debt | 14 | 14 | 23 | 0.79 | 0 | 0 |
Net Cash (Debt) | 148.75 | 144.38 | 158.77 | 329.63 | 288.42 | 239.83 |
Net Cash Growth | 3.03% | -9.06% | -51.84% | 14.29% | 20.26% | -23.11% |
Net Cash Per Share | 8.09 | 7.77 | 8.29 | 17.04 | 14.94 | 11.79 |
Book Value | 543.55 | 533.1 | 532.11 | 497.2 | 434.47 | 395.12 |
Book Value Per Share | 29.56 | 28.70 | 27.77 | 25.70 | 22.50 | 19.42 |
Tangible Book Value | 276.52 | 261.99 | 236.12 | 450.18 | 384.67 | 347.01 |
Tangible Book Value Per Share | 15.04 | 14.11 | 12.32 | 23.27 | 19.92 | 17.06 |